Pharmaceutical Wholesale Group Centered on a Joint Holding Company
First written in FY2016. . Latest entry: FY2026.
1 other company's latest entry also says "Other".
- FY2026Update to Consolidation Scope and Business StructureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 23 subsidiaries and 4 affiliates, and primarily operates businesses relating to 5 segments: pharmaceutical wholesale, pharmacy, veterinary pharmaceutical wholesale, pharmaceuticals and nursing-care rentals and Other,」
The business classification has been changed to 5 segments to reflect the acquisition, establishment and organisational restructuring involving 共和運送, 八千代ケアサポート and メドリープファーマ, among others. - FY2026-H1Update to Consolidation Scope and Business StructureAnnual report
「共和運送㈱, newly acquired, and ㈱メドリープファーマ, newly established, have been included in the scope of consolidation from the current interim consolidated accounting period.」
The scope of consolidation has been updated to reflect the acquisition of 共和運送株式会社 and the establishment of メドリープファーマ. - FY2025Update to Group structureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 18 subsidiaries and 5 affiliates,」
The number of affiliates has been updated from 4 to 5 to reflect アローメディカル becoming a consolidated subsidiary. - FY2025-H1Update to the group structure through the acquisition of a consolidated subsidiaryAnnual report
「Also in August, ㈱アグロジャパン, a consolidated subsidiary in the veterinary pharmaceutical wholesale business, acquired 90% of the shares of アローメディカル㈱, a peer company headquartered in Yokohama, Kanagawa Prefecture, and made it a consolidated subsidiary.」
The group structure has been updated after アグロジャパン acquired 90% of アローメディカル's shares and made it a consolidated subsidiary. - FY2024Update to Group structureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 19 subsidiaries and 4 affiliates, and primarily operates businesses relating to 4 segments: pharmaceutical wholesale, pharmacy, veterinary pharmaceutical wholesale and Other.」
The group structure has been updated to 19 subsidiaries and 4 affiliates. - FY2024-Q2Scope-of-Consolidation UpdateAnnual report
「㈲天王保険調剤センター, newly acquired, has been included in the scope of consolidation from the current second quarter.」
The newly acquired ㈲天王保険調剤センター has been included in the scope of consolidation from the second quarter of FY2024. - FY2023Update to Group structureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 18 subsidiaries and 4 affiliates, and primarily operates businesses relating to 4 segments: pharmaceutical wholesale, pharmacy, veterinary pharmaceutical wholesale and Other.」
The group structure has been updated to 18 subsidiaries and 4 affiliates. - FY2023-Q2Scope-of-Consolidation UpdateAnnual report
「塩釜蠻紅華湯㈱ had been included in the scope of consolidation from the first quarter, but ceased to exist during the current second quarter following an absorption-type merger in which ㈱バイタルネット, a consolidated subsidiary of the Company, was the surviving company, and was therefore excluded from the scope of consolidation.」
塩釜蠻紅華湯㈱, added to the scope of consolidation in the first quarter of FY2023, was excluded from the scope of consolidation in the second quarter following an absorption-type merger in which バイタルネット was the surviving company. - FY2023-Q1Update to the scope of consolidation and planned absorption-type mergerAnnual report
「塩釜蠻紅華湯㈱, scheduled to carry out an absorption-type merger with consolidated subsidiary ㈱バイタルネット on 1 August 2022, has been included in the scope of consolidation from the current first quarter.」
塩釜蠻紅華湯㈱ was added to the scope of consolidation, and the planned absorption-type merger with バイタルネット on 1 August 2022 was disclosed. - FY2022Update to Group structureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 20 subsidiaries and 4 affiliates, and primarily operates businesses relating to 4 segments: pharmaceutical wholesale, pharmacy, veterinary pharmaceutical wholesale and Other.」
The group structure has been updated to 20 subsidiaries and 4 affiliates and 4 segments, with the pharmacy business treated as a separate reportable segment. - FY2022-Q1Scope-of-Consolidation UpdateAnnual report
「㈲健康堂薬局, newly acquired, has been included in the scope of consolidation from the current first quarter.」
The newly acquired 健康堂薬局 has been included in the scope of consolidation from the current first quarter. - FY2021Update to Group structureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 20 subsidiaries and 5 affiliates, and primarily operates businesses relating to 3 segments: pharmaceutical wholesale, veterinary pharmaceutical wholesale and Other.」
The group structure has been updated to 20 subsidiaries and 5 affiliates, and the business classification has been changed to 3 segments. - FY2021-Q2Scope-of-Consolidation UpdateAnnual report
「In the current second quarter, ㈱ヘルスマート, formerly a consolidated subsidiary of the Company, ceased to exist following an absorption-type merger in which ㈱グッドネイバー, a consolidated subsidiary of the Company, was the surviving company, and was therefore excluded from the scope of consolidation.」
ヘルスマート was excluded from the scope of consolidation following its absorption-type merger, with グッドネイバー as the surviving company. - FY2021-Q1Scope-of-Consolidation UpdateAnnual report
「㈱グッドネイバー, whose materiality has increased, has been included in the scope of consolidation from the current first quarter.」
グッドネイバー, whose materiality has increased, was included in the scope of consolidation from the current first quarter. - FY2020Update to Group structureAnnual report
「The Group (the Company and its affiliated companies) comprises the Company, 22 subsidiaries and 4 affiliates,」
The group structure has been updated to 22 subsidiaries and 4 affiliates. - FY2019Update to Group structureAnnual report
「Our group, consisting of our company and its affiliated companies, comprises our company, 23 subsidiaries and 4 associates, and is primarily engaged in businesses relating to 2 segments: pharmaceutical wholesaling and Other.」
The group structure has been updated to 23 subsidiaries and 4 affiliates. - FY2018Update to Group structureAnnual report
「Our group, consisting of our company and its affiliated companies, comprises our company, 22 subsidiaries and 3 associates, and is primarily engaged in businesses relating to 2 segments: pharmaceutical wholesaling and Other. On 1 April 2017, our company conducted an absorption-type merger with VKシェアードサービス株式会社, with our company as the surviving company and VKシェアードサービス株式会社 as the absorbed company.」
The group structure has been updated to 22 subsidiaries and 3 associates, and the absorption-type merger with VKシェアードサービス株式会社 is described. - FY2017Update to Group structureAnnual report
「Our group, consisting of our company and its affiliated companies, comprises our company, 24 subsidiaries and 3 associates, and is primarily engaged in businesses relating to 2 segments: pharmaceutical wholesaling and Other. On 1 April 2017, our company conducted an absorption-type merger with VKシェアードサービス株式会社, with our company as the surviving company and VKシェアードサービス株式会社 as the absorbed company.」
The composition of subsidiaries and associates has been updated, and the 1 April 2017 absorption-type merger with VKシェアードサービス株式会社 is also described. - FY2016First statedAnnual report
「Our group, consisting of our company and its affiliated companies, comprises our company, 23 subsidiaries and 4 associates, and is primarily engaged in businesses relating to 2 segments: pharmaceutical wholesaling and Other.」
A group structure centered on pharmaceutical wholesaling, including retail, agricultural and veterinary pharmaceuticals, transportation, nursing care and consulting.